Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001293971-24-000079
Filing Date
2024-11-14
Accepted
2024-11-14 07:06:40
Documents
89
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q blue-20240930.htm   iXBRL 10-Q 2333631
2 EX-10.4 blue-20240930xex104.htm EX-10.4 224594
3 EX-10.5 blue-20240930xex105.htm EX-10.5 458413
4 EX-31.1 blue-20240930xex311.htm EX-31.1 8111
5 EX-31.2 blue-20240930xex312.htm EX-31.2 8428
6 EX-32.1 blue-20240930xex321.htm EX-32.1 6537
  Complete submission text file 0001293971-24-000079.txt   12405935

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20240930.xsd EX-101.SCH 60375
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blue-20240930_cal.xml EX-101.CAL 84640
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blue-20240930_def.xml EX-101.DEF 325125
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20240930_lab.xml EX-101.LAB 749002
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20240930_pre.xml EX-101.PRE 569999
92 EXTRACTED XBRL INSTANCE DOCUMENT blue-20240930_htm.xml XML 2221525
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35966 | Film No.: 241457140
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)